Patent Assignment
Reel/Frame 047949/0780
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 045035 Frame: 0356. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2018-12-18
Pages: 4
Assignor
ASTRAZENECA CANADA INC.
Executed: 2011-05-17
Assignee
ASTRAZENECA AB
SE-151 85, SÖDERTÄLJE, SWEDEN
Covered Property
(1)
Imidazopyridine Compounds and Uses Thereof
Related Assignments
(9)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 26, 2018
From: BUON, CHRISTOPHE; CANTIN, LOUIS-DAVID; HU, YUN-JIN; LUO, XUEHONG
To: ASTRAZENECA CANADA INC.
Reel/Frame 045034/0906 →
Assignment of Assignor's Interest
Feb 26, 2018
From: ASTRAZENECA CANADA INC.
To: ASTRAZENECA CANADA AB
Reel/Frame 045035/0356 →
Assignment of Assignor's Interest
Feb 26, 2018
From: ASTRAZENECA AB
To: NEOMED INSTITUTE
Reel/Frame 045035/0418 →
Assignment of Assignor's Interest
Aug 24, 2022
From: NEOMED INSTITUTE
To: BELLUS HEALTH COUGH INC.
Reel/Frame 060884/0013 →
Merger
Aug 9, 2023
From: BELLUS HEALTH COUGH INC.
To: BELLUS HEALTH INC.
Reel/Frame 064531/0830 →
Assignment of Assignor's Interest
Aug 9, 2023
From: BELLUS HEALTH INC.
To: 14245563 CANADA INC.
Reel/Frame 065117/0909 →
Assignment of Assignor's Interest
Jan 19, 2024
From: 14245563 CANADA INC.
To: ID BIOMEDICAL CORPORATION OF QUEBEC
Reel/Frame 066353/0331 →
Assignment of Assignor's Interest
Jan 19, 2024
From: ID BIOMEDICAL CORPORATION OF QUEBEC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 066353/0356 →
Change of Address
Apr 16, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 071351/0192 →